Market Cap

CellaVision AB Market Capitalization:

kr5.87 Billion

SEK as of July 1, 2024

US$552.8 Million

business CellaVision AB Company Profile

CellaVision AB Main Stock Listing

OMX: CEVI

Market Capitalization History of CellaVision AB

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Medical Devices
Company Market Cap (USD)
Abbott $178.02 B
Stryker Corporation $126.48 B
Boston Scientific Corporation $112.32 B
Medtronic $98.95 B
Edwards Lifesciences Corporation $55.63 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of CellaVision AB market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr4.98 B -9.62%
Jan. 1, 2023 kr5.51 B -25.64%
Jan. 1, 2022 kr7.42 B 2.09%
Jan. 1, 2021 kr7.26 B -11.12%
Jan. 1, 2020 kr8.17 B 37.58%
Jan. 1, 2019 kr5.94 B 54.69%
Jan. 1, 2018 kr3.84 B 59.09%
Jan. 1, 2017 kr2.41 B 54.51%
Jan. 1, 2016 kr1.56 B 54.36%
Jan. 1, 2015 kr1.01 B 115.10%
Jan. 1, 2014 kr470.6 M 20.00%
Jan. 1, 2013 kr392.1 M 15.11%
Jan. 1, 2012 kr340.7 M 3.35%
Jan. 1, 2011 kr329.6 M -4.61%
Jan. 1, 2010 kr345.6 M 168.57%
Jan. 1, 2009 kr128.7 M 15.64%
Jan. 1, 2008 kr111.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

CellaVision AB Categories

Sweden languages Healthcare languages Medical Devices
Sweden Healthcare Sweden Medical Devices

Stocks & Indices

CellaVision AB has the following listings and related stock indices.


Stock: OMX: CEVI

Stock: FSX: C26

Stock: OTC: CLVSF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.